Clinical Immunology and Immunopathology, 0090-1229

Journal

  1. 1998
  2. Planken, EV., Van de Velde, H., Falkenburg, JHF., Thielemans, K., Willemze, R., & Kluin-Nelemans, JC. (1998). Selective response of CD5(+) B cell malignancies to activation of the CD72 antigen. Clinical Immunology and Immunopathology, 87(1), 42-49.
  3. 1991
  4. 1989
  5. 1988
  6. 1986
  7. 1985
  8. Kallenberg, C., KLAASSEN, R. J. L., BEELEN, J. M., & The, T. H. (1985). HLA-B8/DR3 PHENOTYPE AND THE PRIMARY IMMUNE-RESPONSE. Clinical Immunology and Immunopathology, 34(1), 135-140.
  9. 1983
  10. 1982
  11. 1981
  12. TENBERGE, RJM., SCHELLEKENS, PTA., SURACHNO, S., THE, TH., TENVEEN, JH., & WILMINK, JM. (1981). THE INFLUENCE OF THERAPY WITH AZATHIOPRINE AND PREDNISONE ON THE IMMUNE-SYSTEM OF KIDNEY-TRANSPLANT RECIPIENTS. Clinical Immunology and Immunopathology, 21(1), 20-32.
  13. 1980
  14. WIJERMANS, P., OOSTERHUIS, HJGH., ASTALDI, GCB., SCHELLEKENS, PTA., & ASTALDI, A. (1980). THYMUS-DEPENDENT SERUM FACTOR IN NON-THYMECTOMIZED AND THYMECTOMIZED PATIENTS WITH MYASTHENIA-GRAVIS. Clinical Immunology and Immunopathology, 16(1), 11-18.

ID: 2009918